Primary tumor (T)* | |||
TX: Primary tumor cannot be assessed | |||
T0: No evidence of primary tumor | |||
Tis: Carcinoma in situ or PanInIII | |||
T1: Tumor limited to the pancreas and ≤2 cm in greatest diameter | |||
T2: Tumor limited to the pancreas and >2 cm in greatest diameter | |||
T3: Tumor extends beyond the pancreas but does not involve the celiac axis or SMA | |||
T4: Tumor involves the celiac axis or SMA | |||
Regional lymph nodes (N) | |||
NX: Regional lymph nodes cannot be assessed | |||
N0: No regional lymph node involvement | |||
N1: Regional lymph node metastases | |||
Distant metastases (M) | |||
M0: No distant metastases | |||
M1: Distant metastases | |||
| |||
Stage grouping based on TNM classification | |||
0 | T0, Tis | N0 | N0 |
| |||
I | T1 or T2 | N0 | M0 |
| |||
II | T3 | N0 | M0 |
| |||
T1–T3 | N1 | M0 | |
| |||
III | T4 | Any N | M0 |
| |||
IV | Any T | Any N | M1 |
Primary tumor was assessed by contrast-enhanced CT scan.